Product References
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene.
Stem cell research
Rotundo G,Turco EM,Ruotolo G,Torrente I,Candido O,Lopez G,Ferrari D,Caputi C,Mastrangelo M,Pisani F,Gelati M,Guarnieri V,Vescovi AL,Rosati J
41-1000 was used in Immunocytochemistry-immunofluorescence to study p.T972M amino acid substitution in cytoplasmic tail of CasR, produced froma virus, xeno-free and non-integrative protocol.
Wed Mar 01 00:00:00 EST 2023
Generation of iPSC-derived human forebrain organoids assembling bilateral eye primordia.
Nature protocols
Gabriel E,Albanna W,Pasquini G,Ramani A,Josipovic N,Mariappan A,Riparbelli MG,Callaini G,Karch CM,Goureau O,Papantonis A,Busskamp V,Schneider T,Gopalakrishnan J
41-1000 was used in Immunocytochemistry to generate organoids with both forebrain entities, which we call OV-containing brain organoids (OVB organoids).
Thu Jun 01 00:00:00 EDT 2023
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein.
Stem cell research
D'Anzi A,Perciballi E,Ruotolo G,Ferrari D,Notaro A,Lombardi I,Gelati M,Frezza K,Bernardini L,Torrente I,De Luca A,La Bella V,Luigi Vescovi A,Rosati J
41-1000 was used in Immunocytochemistry-immunofluorescence to generate a human induced pluripotent stem cell (hiPSC) line from the fibroblasts of an asymptomatic subject carrying the TARDBP p.G376D mutation, which is rare and associated with familial Amyotrophic Lateral Sclerosis (ALS).
Mon Aug 01 00:00:00 EDT 2022
Generation and characterization of a human induced pluripotent stem cell (iPSC) line from a patient with congenital heart disease (CHD).
Stem cell research
Lin H,Ye SQ,Xu ZH,Penaloza JS,Aljuhani M,Vetter T,Zhao MT,McBride KL
41-1000 was used in Flow Cytometry to show that NCHi001-A can be used for disease modeling, drug discovery, and cell therapy development.
Thu Dec 01 00:00:00 EST 2022
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein.
Stem cell research
D'Anzi A,Altieri F,Perciballi E,Ferrari D,Torres B,Bernardini L,Lattante S,Sabatelli M,Vescovi AL,Rosati J
41-1000 was used in Flow Cytometry to show that this cell line may prove useful in the study of the pathogenic mechanisms that underpin ALS syndrome.
Sat May 01 00:00:00 EDT 2021
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein.
Stem cell research
D'Anzi A,Altieri F,Perciballi E,Ferrari D,Torres B,Bernardini L,Lattante S,Sabatelli M,Vescovi AL,Rosati J
41-1000 was used in Flow Cytometry to show that this cell line may prove useful in the study of the pathogenic mechanisms that underpin ALS syndrome.
Sat May 01 00:00:00 EDT 2021
Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
Stem cell research
Fatima A,Schuster J,Akram T,Sobol M,Hoeber J,Dahl N
41-1000 was used in Immunocytochemistry to generate a Neurochondrin deficient human iPSC line KICRi002-A-3 carrying a homozygous 752 bp deletion / 2 bp insertion in the NCDN gene.
Wed Apr 01 00:00:00 EDT 2020
Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9.
Stem cell research
Fatima A,Schuster J,Akram T,González CM,Sobol M,Hoeber J,Dahl N
41-1000 was used in Immunocytochemistry to generate an IKBKG knock-out iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9 technology.
Wed Apr 01 00:00:00 EDT 2020
Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors.
Stem cell research
Vasylovska S,Schuster J,Brboric A,Carlsson PO,Dahl N,Lau J
41-1000 was used in Immunocytochemistry-immunofluorescence to generate two human iPSC lines from dermal fibroblasts of two healthy females using Sendai virus reprogramming.
Wed Dec 09 00:00:00 EST 2020
Derivation of Induced Pluripotent Stem Cells from Human Fibroblasts Using a Non-integrative System in Feeder-free Conditions.
Bio-protocol
Beltran AA,Molina SG,Beltran AS
41-1000 was used in Immunocytochemistry-immunofluorescence to describe a feeder-free non-integrative system for iPSC.
Tue Oct 20 00:00:00 EDT 2020
Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations.
Stem cell research
Schuster J,Fatima A,Schwarz F,Klar J,Laan L,Dahl N
41-1000 was used in Flow Cytometry to offer a useful resource to study disease pathophysiology and for anti-cancer drug development.
Mon Jul 01 00:00:00 EDT 2019
Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Stem cell research
Schuster J,Fatima A,Sobol M,Norradin FH,Laan L,Dahl N
41-1000 was used in Immunocytochemistry, Flow Cytometry to show that these iPSC lines offer a useful resource to investigate the molecular mechanisms underlying Nav1.1 haploinsufficiency and for drug development to improve treatment of DS patients.
Thu Aug 01 00:00:00 EDT 2019
Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Stem cell research
Schuster J,Fatima A,Sobol M,Norradin FH,Laan L,Dahl N
41-1000 was used in Immunocytochemistry, Flow Cytometry to show that these iPSC lines offer a useful resource to investigate the molecular mechanisms underlying Nav1.1 haploinsufficiency and for drug development to improve treatment of DS patients.
Thu Aug 01 00:00:00 EDT 2019
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome.
Stem cell research
Altieri F,D'Anzi A,Martello F,Tardivo S,Spasari I,Ferrari D,Bernardini L,Lamorte G,Mazzoccoli G,Valente EM,Vescovi AL,Rosati J
41-1000 was used in Immunocytochemistry to produce human induced pluripotent stem cells containing the homozygous missense mutation in the AHI1 gene from a patient with Joubert syndrome.
Mon Jul 01 00:00:00 EDT 2019
Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
eLife
Battaglia RA,Beltran AS,Delic S,Dumitru R,Robinson JA,Kabiraj P,Herring LE,Madden VJ,Ravinder N,Willems E,Newman RA,Quinlan RA,Goldman JE,Perng MD,Inagaki M,Snider NT
Published figure using TRA-1-60 monoclonal antibody (Product # 41-1000) in Immunocytochemistry
Mon Nov 04 00:00:00 EST 2019
Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors.
Cells
Shrestha R,Wen YT,Ding DC,Tsai RK
41-1000 was used in Immunocytochemistry-immunoflourescence to show that human induced pluripotent stem cells with abnormal chromosomal content are permissive to the generation of three-dimensional retinal organoids.
Wed Jan 09 00:00:00 EST 2019
Effects of various culture conditions on pluripotent stem cell derivation from chick embryos.
Journal of cellular biochemistry
Farzaneh M,Zare M,Hassani SN,Baharvand H
Published figure using TRA-1-60 monoclonal antibody (Product # 41-1000) in Immunocytochemistry
Wed Aug 01 00:00:00 EDT 2018
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Stem cell research
Bidollari E,Rotundo G,Ferrari D,Candido O,Bernardini L,Consoli F,De Luca A,Santimone I,Lamorte G,Ilari A,Squitieri F,Vescovi AL,Rosati J
41-1000 was used in Immunocytochemistry-immunofluorescence to generate a human iPS cell line from skin fibroblasts of a subject at the presymptomatic life stage, carrying a polyglutamine expansion in HTT gene codifying Huntingtin protein.
Sun Apr 01 00:00:00 EDT 2018
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850).
Stem cell research
Rosati J,Altieri F,Tardivo S,Turco EM,Goldoni M,Spasari I,Ferrari D,Bernardini L,Lamorte G,Valente EM,Vescovi AL
41-1000 was used in Immunocytochemistry-immunofluorescence to elucidate ciliopathy-associated molecular mechanisms using human induced pluripotent stem cells (hiPSCs) were derived from a patient affected by JS carrying a homozygous missense mutation in the AHI1 gene (p.H896R) that encodes a protein named Jouberin.
Thu Mar 01 00:00:00 EST 2018
Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells.
Cell death & disease
De Angelis MT,Parrotta EI,Santamaria G,Cuda G
41-1000 was used in Immunocytochemistry-immunoflourescence to uncover a novel role for retinoic acid in favouring the maintenance of ground-state pluripotency.
Fri Jan 05 00:00:00 EST 2018
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease.
Stem cell research
Rotundo G,Bidollari E,Ferrari D,Spasari I,Bernardini L,Consoli F,De Luca A,Santimone I,Lamorte G,Migliore S,Squitieri F,Vescovi AL,Rosati J
41-1000 was used in Immunocytochemistry, Western Blot, Flow Cytometry to investigate iPSC generation from a patient with Huntington's Disease.
Tue May 01 00:00:00 EDT 2018
Rapid DNA replication origin licensing protects stem cell pluripotency.
eLife
Matson JP,Dumitru R,Coryell P,Baxley RM,Chen W,Twaroski K,Webber BR,Tolar J,Bielinsky AK,Purvis JE,Cook JG
41-1000 was used in Western Blotting to demonstrate that rapid origin licensing is an intrinsic characteristic of stem cells that contributes to pluripotency maintenance.
Fri Nov 17 00:00:00 EST 2017
Mouse iPSC generated with porcine reprogramming factors as a model for studying the effects of non-silenced heterologous transgenes on pluripotency.
Journal of stem cells & regenerative medicine
Petkov SG,Glage S,Niemann H
41-1000 was used in Immunocytochemistry to evaluate the ability of transposon-based vectors with porcine pluripotency factors to reprogram mouse foetal fibroblasts to pluripotency.
Wed Sep 30 00:00:00 EDT 2020
Comparative epigenetic evaluation of human embryonic stem and induced pluripotent cells.
The International journal of developmental biology
Favaedi R,Shahhoseini M,Pakzad M,Mollamohammadi S,Baharvand H
41-1000 was used in Immunocytochemistry to evaluate the epigenetic profiles of human embryonic stem and induced pluripotent cells.
Wed Jan 31 00:00:00 EST 2018
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
Disease models & mechanisms
Lenzi J,De Santis R,de Turris V,Morlando M,Laneve P,Calvo A,Caliendo V,Chiò A,Rosa A,Bozzoni I
41-1000 was used in immunocytochemistry to study induced pluripotent stem cells derived from patients with amyotrophic lateral sclerosis
Wed Jul 01 00:00:00 EDT 2015
Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.
Frontiers in cellular neuroscience
Alves CJ,Dariolli R,Jorge FM,Monteiro MR,Maximino JR,Martins RS,Strauss BE,Krieger JE,Callegaro D,Chadi G
Published figure using TRA-1-60 monoclonal antibody (Product # 41-1000) in Immunofluorescence
Mon Aug 24 00:00:00 EDT 2015
Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells.
Nature protocols
Wong AP,Chin S,Xia S,Garner J,Bear CE,Rossant J
41-1000 was used in western blot to describe a method to generate cystic fibrosis transmembrane conductance regulator protein-expressing airway epithelial cells from human pluripotent stem cells
Sun Mar 01 00:00:00 EST 2015
Directed differentiation of human pluripotent cells to neural crest stem cells.
Nature protocols
Menendez L,Kulik MJ,Page AT,Park SS,Lauderdale JD,Cunningham ML,Dalton S
41-1000 was used in Immunocytochemistry-immunofluorescence to describes how to perform a highly efficient, lineage-specific differentiation of human pluripotent cells to a NCSC fate.
Tue Jan 01 00:00:00 EST 2013
Cellular characterization of human pluripotent stem cells.
Methods in molecular biology (Clifton, N.J.)
Quintanilla RH
Thu Sep 19 00:00:00 EDT 2013
Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.
Stem cells international
Macarthur CC,Fontes A,Ravinder N,Kuninger D,Kaur J,Bailey M,Taliana A,Vemuri MC,Lieu PT
Published figure using TRA-1-60 monoclonal antibody (Product # 41-1000) in Immunofluorescence
Fri Jul 13 00:00:00 EDT 2012
Applications of quantitative polymerase chain reaction protein assays during reprogramming.
Stem cells and development
Ruff D,MacArthur C,Tran H,Bergseid J,Tian J,Shannon M,Chen SM,Fontes A,Laurent L,Swartzman E,Taliana A,Rao M,Lieu PT
Thu Mar 01 00:00:00 EST 2012
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency.
Nature methods
Hotta A,Cheung AY,Farra N,Vijayaragavan K,Séguin CA,Draper JS,Pasceri P,Maksakova IA,Mager DL,Rossant J,Bhatia M,Ellis J
41-1000 was used in flow cytometry and immunocytochemistry to report the first selection system for the isolation of human induced pluripotent stem cells
Fri May 01 00:00:00 EDT 2009
Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens.
Stem cells (Dayton, Ohio)
Henderson JK,Draper JS,Baillie HS,Fishel S,Thomson JA,Moore H,Andrews PW
Wed Jan 08 00:00:00 EST 2003
Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens.
Stem cells (Dayton, Ohio)
Henderson JK,Draper JS,Baillie HS,Fishel S,Thomson JA,Moore H,Andrews PW
Wed Jan 08 00:00:00 EST 2003
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.
International journal of cancer
Andrews PW,Casper J,Damjanov I,Duggan-Keen M,Giwercman A,Hata J,von Keitz A,Looijenga LH,Millán JL,Oosterhuis JW,Pera M,Sawada M,Schmoll HJ,Skakkebaek NE,van Putten W,Stern P
Tue Jun 11 00:00:00 EDT 1996
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.
International journal of cancer
Andrews PW,Casper J,Damjanov I,Duggan-Keen M,Giwercman A,Hata J,von Keitz A,Looijenga LH,Millán JL,Oosterhuis JW,Pera M,Sawada M,Schmoll HJ,Skakkebaek NE,van Putten W,Stern P
Tue Jun 11 00:00:00 EDT 1996
